Magnus Koping-Hoggard
Overview
Explore the profile of Magnus Koping-Hoggard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Issa M, Koping-Hoggard M, Artursson P
Drug Discov Today Technol
. 2014 Jul;
2(1):1-6.
PMID: 24981748
Recent human and animal studies have indicated that chitosan-based delivery systems are promising alternatives to conventional formulation approaches for the mucosal delivery of biotechnology drugs, such as proteins and genes....
2.
Csaba N, Koping-Hoggard M, Fernandez-Megia E, Novoa-Carballal R, Riguera R, Alonso M
J Biomed Nanotechnol
. 2010 Jan;
5(2):162-71.
PMID: 20055094
The purpose of this work was to develop a new type of nanoparticles made of PEG-grafted chi-tosans (CS-g-PEG) using tripolyphosphate (TPP) as a polyanionic crosslinker and to investigate the potential...
3.
Csaba N, Koping-Hoggard M, Alonso M
Int J Pharm
. 2009 Aug;
382(1-2):205-14.
PMID: 19660537
Ionically crosslinked nanoparticles based on high and low molecular weight chitosans (CS) were formulated with plasmid DNA or dsDNA oligomers using the ionic gelation technique with pentasodium tripolyphospate (TPP) as...
4.
Issa M, Koping-Hoggard M, Tommeraas K, Varum K, Christensen B, Strand S, et al.
J Control Release
. 2006 Aug;
115(1):103-12.
PMID: 16901570
The aim of this study was to improve the gene delivery efficacy of chitosan oligomer polyplexes by introducing a trisaccharide branch that targets cell-surface lectins. For this purpose, chitosan oligomers...
5.
Regnstrom K, Ragnarsson E, Fryknas M, Koping-Hoggard M, Artursson P
Pharm Res
. 2006 Feb;
23(3):475-82.
PMID: 16463010
Purpose: This study compared gene expression profiles in mouse lungs after administration of the cationic polymers polyethyleneimine (PEI) or chitosan alone or formulated with a luciferase reporter plasmid (PEI-pLuc, chitosan-pLuc)....
6.
Koping-Hoggard M, Issa M, Kohler T, Tronde A, Varum K, Artursson P
J Gene Med
. 2005 May;
7(9):1215-22.
PMID: 15895386
Background: The available methods for administration of gene delivery systems to the lungs of small animals via nebulization have several drawbacks. These include lack of control over the delivered dose...
7.
Koping-Hoggard M, Sanchez A, Alonso M
Expert Rev Vaccines
. 2005 May;
4(2):185-96.
PMID: 15889992
At present, there is considerable excitement within the nanotechnology field with regard to the potential use of nanosystems as carriers for mucosal vaccine delivery. Indeed, many of the vaccines available,...
8.
Tommeraas K, Koping-Hoggard M, Varum K, Christensen B, Artursson P, Smidsrod O
Carbohydr Res
. 2002 Dec;
337(24):2455-62.
PMID: 12493230
The trimer 2-acetamido-2-deoxy-D-glucopyranosyl-beta-(1-->4)-2-acetamido-2-deoxy-D-glucopyranosyl-beta-(1-->4)-2,5-anhydro-D-mannofuranose (A-A-M) was reductively N-alkylated onto a fully de-N-acetylated chitosan (F(A)<0.001, DP(n)=25) to obtain branched chitosans with degree of substitution (DS) of 0.070, 0.23 and 0.40, as determined...